Biochemical Control and Toxicity Outcomes of Stereotactic Body Radiation Therapy Versus Low-Dose-Rate Brachytherapy in the Treatment of Low- and Intermediate-Risk Prostate Cancer-Reference-Cited by-同舟云学术

Biochemical Control and Toxicity Outcomes of Stereotactic Body Radiation Therapy Versus Low-Dose-Rate Brachytherapy in the Treatment of Low- and Intermediate-Risk Prostate Cancer

Published:2021-04 Issue:5 Volume:109 Page:1232-1242
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Gogineni Emile,Rana Zaker,Soberman Danielle,Sidiqi Baho,D'Andrea Vincent,Lee Lucille,Potters Louis,Parashar Bhupesh^ORCID

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Radiation

Reference52 articles.

1. Dose-fractionation sensitivity of prostate cancer deduced from radiotherapy outcomes of 5,969 patients in seven international institutional datasets: Α/β = 1.4 (0.9-2.2) Gy;Miralbell;Int J Radiat Oncol Biol Phys,2012

2. Estimation of α/β for late rectal toxicity based on RTOG 94-06;Tucker;Int J Radiat Oncol Biol Phys,2011

3. Primary treatments for clinically localised prostate cancer: A comprehensive lifetime cost-utility analysis;Cooperberg;BJU Int,2013

4. Model-based cost-effectiveness analysis of external beam radiation therapy for the treatment of localized prostate cancer: A systematic review;Abreha;Cost Eff Resour Alloc,2019

5. Comparative toxicities and cost of intensity-modulated radiotherapy, proton radiation, and stereotactic body radiotherapy among younger men with prostate cancer;Pan;J Clin Oncol,2018

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Photon vs proton hypofractionation in prostate cancer: A systematic review and meta-analysis;Radiotherapy and Oncology;2024-06

2. Efficacy of a hydrogel spacer for improving quality of life in patients with prostate cancer undergoing low‐dose‐rate brachytherapy alone or in combination with intensity‐modulated radiotherapy: An observational study using propensity score matching;The Prostate;2024-05-12

3. Population‐based patient‐reported quality of life outcomes following low‐dose‐rate versus high‐dose‐rate brachytherapy monotherapy for low‐intermediate risk prostate cancer;Journal of Medical Imaging and Radiation Oncology;2023-10

4. A comparison between high dose rate brachytherapy and stereotactic body radiotherapy boost after elective pelvic irradiation for high and very high-risk prostate cancer;Radiation Oncology Journal;2022-09-30

5. Biochemical failure and toxicity in treatment with brachytherapy and external beam radiotherapy compared with radical prostatectomy in localized prostate cancer;Reports of Practical Oncology and Radiotherapy;2022-07-06